403 related articles for article (PubMed ID: 31350093)
1. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
Lappin TR; Lee FS
Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
[TBL] [Abstract][Full Text] [Related]
2. Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline.
Furlow PW; Percy MJ; Sutherland S; Bierl C; McMullin MF; Master SR; Lappin TR; Lee FS
J Biol Chem; 2009 Apr; 284(14):9050-8. PubMed ID: 19208626
[TBL] [Abstract][Full Text] [Related]
3. The HIF pathway and erythrocytosis.
Lee FS; Percy MJ
Annu Rev Pathol; 2011; 6():165-92. PubMed ID: 20939709
[TBL] [Abstract][Full Text] [Related]
4. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.
Percy MJ; Furlow PW; Beer PA; Lappin TR; McMullin MF; Lee FS
Blood; 2007 Sep; 110(6):2193-6. PubMed ID: 17579185
[TBL] [Abstract][Full Text] [Related]
5. Erythrocytosis associated with a novel missense mutation in the HIF2A gene.
van Wijk R; Sutherland S; Van Wesel AC; Huizinga EG; Percy MJ; Bierings M; Lee FS
Haematologica; 2010 May; 95(5):829-32. PubMed ID: 20007141
[TBL] [Abstract][Full Text] [Related]
6. Congenital erythrocytosis.
Mallik N; Das R; Malhotra P; Sharma P
Eur J Haematol; 2021 Jul; 107(1):29-37. PubMed ID: 33840141
[TBL] [Abstract][Full Text] [Related]
7. Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation.
Tan Q; Kerestes H; Percy MJ; Pietrofesa R; Chen L; Khurana TS; Christofidou-Solomidou M; Lappin TR; Lee FS
J Biol Chem; 2013 Jun; 288(24):17134-44. PubMed ID: 23640890
[TBL] [Abstract][Full Text] [Related]
8. VHL gene methylation contributes to excessive erythrocytosis in chronic mountain sickness rat model by upregulating the HIF-2α/EPO pathway.
Yang M; Zhu M; Song K; Wuren T; Yan J; Ge RL; Ji L; Cui S
Life Sci; 2021 Feb; 266():118873. PubMed ID: 33309718
[TBL] [Abstract][Full Text] [Related]
9. Oxygen sensing: recent insights from idiopathic erythrocytosis.
Lee FS; Percy MJ; McMullin MF
Cell Cycle; 2006 May; 5(9):941-5. PubMed ID: 16687917
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Erythropoiesis by the Hypoxia-Inducible Factor Pathway: Effects of Genetic and Pharmacological Perturbations.
Semenza GL
Annu Rev Med; 2023 Jan; 74():307-319. PubMed ID: 35773226
[TBL] [Abstract][Full Text] [Related]
11. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.
Semenza GL
Blood; 2009 Sep; 114(10):2015-9. PubMed ID: 19494350
[TBL] [Abstract][Full Text] [Related]
12. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
Gong K; Zhang N; Zhang K; Na Y
Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
14. Novel Homozygous Mutation of the Internal Translation Initiation Start Site of VHL is Exclusively Associated with Erythrocytosis: Indications for Distinct Functional Roles of von Hippel-Lindau Tumor Suppressor Isoforms.
Bartels M; van der Zalm MM; van Oirschot BA; Lee FS; Giles RH; Kruip MJ; Gitz-Francois JJ; Van Solinge WW; Bierings M; van Wijk R
Hum Mutat; 2015 Nov; 36(11):1039-42. PubMed ID: 26224408
[TBL] [Abstract][Full Text] [Related]
15. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.
Pastore Y; Jedlickova K; Guan Y; Liu E; Fahner J; Hasle H; Prchal JF; Prchal JT
Am J Hum Genet; 2003 Aug; 73(2):412-9. PubMed ID: 12844285
[TBL] [Abstract][Full Text] [Related]
16. A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism.
Arsenault PR; Pei F; Lee R; Kerestes H; Percy MJ; Keith B; Simon MC; Lappin TRJ; Khurana TS; Lee FS
J Biol Chem; 2013 Nov; 288(47):33571-33584. PubMed ID: 24121508
[TBL] [Abstract][Full Text] [Related]
17. Polycythemia and oxygen sensing.
Maran J; Prchal J
Pathol Biol (Paris); 2004 Jun; 52(5):280-4. PubMed ID: 15217714
[TBL] [Abstract][Full Text] [Related]
18. The role of PHD2 mutations in the pathogenesis of erythrocytosis.
Gardie B; Percy MJ; Hoogewijs D; Chowdhury R; Bento C; Arsenault PR; Richard S; Almeida H; Ewing J; Lambert F; McMullin MF; Schofield CJ; Lee FS
Hypoxia (Auckl); 2014; 2():71-90. PubMed ID: 27774468
[TBL] [Abstract][Full Text] [Related]
19. Erythrocytosis: the HIF pathway in control.
Franke K; Gassmann M; Wielockx B
Blood; 2013 Aug; 122(7):1122-8. PubMed ID: 23733342
[TBL] [Abstract][Full Text] [Related]
20. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins.
Takeda K; Aguila HL; Parikh NS; Li X; Lamothe K; Duan LJ; Takeda H; Lee FS; Fong GH
Blood; 2008 Mar; 111(6):3229-35. PubMed ID: 18056838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]